M. Avril

发表

Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.

D. Stoppa-Lyonnet, J. Bénard, A. Chompret, 1998, Human molecular genetics.

Vemurafenib pharmacokinetics and its correlation with efficacy and safety in outpatients with advanced BRAF-mutated melanoma

F. Goldwasser, N. Dupin, L. Mortier, 2016, Targeted Oncology.

Patterns of familial aggregation of three melanoma risk factors: great number of naevi, light phototype and high degree of sun exposure.

A. Chompret, L. Briollais, F. Demenais, 2000, International journal of epidemiology.

Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect

A. Goldstein, T. Frebourg, A. Chompret, 2001, Genes, chromosomes & cancer.

A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families.

J. Struewing, M. Tucker, A. Goldstein, 2000, American journal of human genetics.

Association between germ cell tumours, large numbers of naevi, atypical naevi and melanoma

C. Théodore, A. Chompret, F. Demenais, 2001, Melanoma research.

Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypes

M. Barrois, A. Chompret, C. Marian, 2009, Familial Cancer.

Lack of effect of pregnancy on outcome of melanoma

N. Cascinelli, A. Morabito, J. Hunter, 1991, The Lancet.

Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma

M. Tucker, A. Goldstein, G. Peters, 2005, Journal of Medical Genetics.

16 ink 4 a / p 14 arf ) and cdkn 2 b genes in 53 melanoma index cases considered to be at heightened risk of melanoma

M. Tucker, G. Peters, M. Barrois, 2005 .

The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma

J. Limacher, M. Barrois, A. Chompret, 2008, British Journal of Cancer.

Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study

S. Puig, E. Gillanders, D. Elder, 2010, Journal of the National Cancer Institute.

Measles immunity and measles vaccine acceptance among healthcare workers in Paris, France.

F. Rozenberg, O. Launay, V. Dumaine, 2013, The Journal of hospital infection.